4 Billion Guidance Was provided at a time when the cannabis sector was bullish on the US legalizing sooner than later.
It's only over the last few months that we have seen the HHS recommendation to the DEA to reschedule cannabis. This is now under review and we may be seeing actual tangible progress before the end of the summer.
Tilray has been growing through acquisition and picking up companies for pennies on the dollar. They may now be getting medmen for pennies as well.
I'm addition to medmen TLRY is also expected to release news on the company which will enable / support their US entry.
The US represents the largest cannabis market in the world. TLRY has products proven both in the Canadian market as well as internationally. There is every reason to expect these same products will perform well within the US market